This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Obesity or Non-Alcoholic Steatohepatitis
and you are
between 22 and 69
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This study is designed to investigate the impact of weight loss achieved with the IGB on NASH with early fibrosis in a select cohort of patients with obesity preselected to have a high pre-test probability of having NASH with early fibrosis based on magnetic resonance elastography (MRE)-Hepatogram. In addition, this study will explore potential non-invasive imaging criteria for NASH and early fibrosis using EUS-Elastography.

Provided treatments

  • Device: Orbera Intragastric Balloon
  • Procedure: Endoscopic Ultrasound Guided Core Liver Biopsy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02880189. The sponsor of the trial is Mayo Clinic and it is looking for 21 volunteers for the current phase.
Official trial title:
Combined Endoscopic Ultrasound Guided Core Liver Biopsy and Intragastric Balloon Placement for the Diagnosis and Management of Nonalcoholic Steatohepatitis and Obesity